Circulating tumor cells can reveal genetic signature of dangerous lung cancers
Massachusetts General Hospital investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.
The rest of the article can be read here.
Related Posts:- Counting tumor cells in blood predicts treatment benefit in prostate cancer
- Scientists discover major genetic cause of colorectal cancer
- Bacterial peptide provides new insight into common tumor suppressor
- Mobilizing white blood cells to the lung: New discovery could lead to an improved influenza vaccine
- Slipping through cell walls, nanotubes deliver high-potency punch to cancer tumors in mice
- Faulty DNA repair could be a risk factor for lung cancer in nonsmokers
- Faulty DNA Repair Could Be A Risk Factor For Lung Cancer In Nonsmokers
- Asthma monitoring on the Web
- New clinical trial for patients with asbestos-associated lung cancer
- Losing sleep
You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
Leave a Reply